Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GBNHNASDAQ:MGRXNASDAQ:NIVFNASDAQ:OTRK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGBNHGreenbrook TMS$0.05$0.09$0.10▼$1.82$1.96M2.193.60 million shs787,000 shsMGRXMangoceuticals$1.47+6.5%$2.31$1.32▼$16.80$7.60M2.45280,060 shs98,777 shsNIVFNewGenIvf Group$2.95-1.0%$5.41$2.58▼$656.00$1.56M0.25129,014 shs154,440 shsOTRKOntrak$1.55-4.3%$1.52$1.27▼$5.53$6.54M2.3454,091 shs43,628 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGBNHGreenbrook TMS0.00%0.00%0.00%0.00%0.00%MGRXMangoceuticals0.00%-16.24%-42.80%-69.63%-97.02%NIVFNewGenIvf Group0.00%-12.72%+4.09%-84.87%-98.84%OTRKOntrak0.00%-5.49%+9.93%-2.52%-61.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGBNHGreenbrook TMSN/AN/AN/AN/AN/AN/AN/AN/AMGRXMangoceuticals0.2819 of 5 stars0.02.00.00.01.71.70.0NIVFNewGenIvf Group0.9987 of 5 stars0.05.00.00.00.63.30.0OTRKOntrak2.3049 of 5 stars3.55.00.00.00.00.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGBNHGreenbrook TMS 0.00N/AN/AN/AMGRXMangoceuticals 0.00N/AN/AN/ANIVFNewGenIvf Group 0.00N/AN/AN/AOTRKOntrak 3.00Buy$45.002,803.23% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGBNHGreenbrook TMS$69.10M0.03N/AN/A($1.72) per share-0.03MGRXMangoceuticals$615.87K12.34N/AN/A$0.54 per share2.72NIVFNewGenIvf Group$5.43M0.29$0.95 per share3.11$2.19 per share1.35OTRKOntrak$10.85M0.60N/AN/A$5.56 per share0.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGBNHGreenbrook TMS-$61.73M-$2.12N/AN/AN/A-83.19%N/A-66.59%N/AMGRXMangoceuticals-$9.21M-$4.85N/A∞N/A-1,237.00%-138.00%-118.88%5/21/2025 (Estimated)NIVFNewGenIvf Group$130KN/A0.00∞N/AN/AN/AN/AN/AOTRKOntrak-$27.92M-$15.81N/AN/AN/A-237.77%-171.34%-113.42%N/ALatest GBNH, MGRX, OTRK, and NIVF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025MGRXMangoceuticalsN/A-$1.29N/A-$1.29N/A$0.11 million4/14/2025Q4 2024OTRKOntrak-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 million3/20/2025Q4 2024MGRXMangoceuticalsN/A-$1.01N/A-$1.01N/A$0.11 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGBNHGreenbrook TMSN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AOTRKOntrakN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGBNHGreenbrook TMSN/A0.470.47MGRXMangoceuticalsN/A0.070.07NIVFNewGenIvf GroupN/AN/AN/AOTRKOntrak0.191.171.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGBNHGreenbrook TMS64.29%MGRXMangoceuticals56.72%NIVFNewGenIvf Group66.24%OTRKOntrak12.95%Insider OwnershipCompanyInsider OwnershipGBNHGreenbrook TMS21.67%MGRXMangoceuticals16.00%NIVFNewGenIvf Group31.80%OTRKOntrak1.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGBNHGreenbrook TMS49240.80 million31.96 millionNot OptionableMGRXMangoceuticals35.17 million1.51 millionNot OptionableNIVFNewGenIvf GroupN/A527,000346,000N/AOTRKOntrak2504.22 million4.14 millionNo DataGBNH, MGRX, OTRK, and NIVF HeadlinesRecent News About These CompaniesOntrak reports Q4 EPS ($9.29) vs. ($4.02) last yearApril 15, 2025 | markets.businessinsider.comOntrak, Inc. (NASDAQ:OTRK) Q4 2024 Earnings Call TranscriptApril 15, 2025 | msn.comOntrak Health to Report 2024 Fourth Quarter Financial Results on April 14, 2025April 10, 2025 | businesswire.comOntrak Secures Medicaid Provider Designation in Two New States, Enhancing Direct Service Delivery CapabilitiesApril 4, 2025 | finance.yahoo.comOntrak secures Medicaid provider designation in two new statesApril 4, 2025 | markets.businessinsider.comOntrak extends strategic partnership with Sentara Health Plans in VirginiaFebruary 19, 2025 | markets.businessinsider.comOntrak Health and Sentara Health Plans Execute Three-year Contract Extension Following Several ExpansionsFebruary 19, 2025 | finance.yahoo.comOntrak Inc. (OTRK) Partners with Intermountain Health to Deliver AI-Powered Behavioral Health SolutionsJanuary 14, 2025 | msn.comOntrak, Inc. (OTRK) Reports Q3 Loss, Lags Revenue EstimatesNovember 13, 2024 | zacks.comOntrak Health Announces 2024 Third Quarter Financial ResultsNovember 13, 2024 | businesswire.comOntrak, Inc. (OTRK) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseNovember 6, 2024 | zacks.comOntrak Health Expands Behavioral Health Solutions with Sentara Health Plans for Commercial and Marketplace PopulationsNovember 6, 2024 | finance.yahoo.comOntrak Health Collaborates with Major Northeast Regional Plan to Bridge HEDIS Care Gaps Using Ontrak Quality SolutionOctober 9, 2024 | finance.yahoo.comAnalysts Predict a $4 Target for Ontrak Inc (OTRK) Stock—What Could Drive It There?October 9, 2024 | bovnews.comONTRAK INC. DL -,0001 (HY10.DU)September 21, 2024 | au.finance.yahoo.comOntrak Inc (HY10.MU)September 21, 2024 | au.finance.yahoo.comOntrak Inc. (HY10.SG)September 21, 2024 | au.finance.yahoo.comOntrak, Inc. Announces Reverse Stock SplitSeptember 19, 2024 | finance.yahoo.comOntrak, Inc. Announces Reverse Stock SplitSeptember 19, 2024 | businesswire.comOntrak Health Demonstrates Significant Improvement in Members’ Quality of Life from ReQoL Mental Health AssessmentSeptember 12, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGBNH, MGRX, OTRK, and NIVF Company DescriptionsGreenbrook TMS NASDAQ:GBNHGreenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.Mangoceuticals NASDAQ:MGRX$1.47 +0.09 (+6.52%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$1.44 -0.03 (-2.04%) As of 05/16/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.NewGenIvf Group NASDAQ:NIVF$2.95 -0.03 (-1.01%) Closing price 05/16/2025 03:59 PM EasternExtended Trading$2.90 -0.05 (-1.66%) As of 05/16/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.Ontrak NASDAQ:OTRK$1.55 -0.07 (-4.32%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$1.62 +0.07 (+4.52%) As of 05/16/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/12 - 05/16 Retail Investors Are Betting Big on Rocket Lab—Should You Too? Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold Vision Taiwan Semiconductor Stock Is The Gift That Keeps on Giving GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine Alibaba's Earnings Just Changed Everything for the Stock Plug Power: Is Q1 Noise An Opportunity for Accumulation? Cisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
